Details for 2019165430
Up to date per 02.04.2026
Actions
Details for 2019165430
Granted/Registered
European Patent
08.01.2020 A
29.09.2021 B1
23.10.2014
US
201462067908 P
16.04.2015
US
201562148656 P
02.07.2015
US
201562188353 P
27.08.2015
US
201562210795 P
C07K 16/18 20060101AFI20191203BHEP
Owner
Singh Molecular Medicine, LLC4708 Rue Bordeaux Lutz, FL 33558US
Representative
Authorized Recipients
Dr. Markus Zollerc/o HGF Europe LLP, Rudolfskai 485020 SalzburgAT
Inventor
Singh, Sunanda4708 Rue Bordeaux Lutz, Florida 33558US
Information about Fees